European database on medical devices (EUDAMED) is the digital backbone for regulatory oversight across the EU medical device and IVD ecosystem. It has been designed to enhance transparency, traceability, and coordination across EU Member States. EUDAMED will be implemented on 28 May 2026. All medical device and IVD stakeholders are expected to comply with EU MDR EUDAMED requirements by this deadline. We have prepared a detailed guide on how EU medical device and IVD manufacturers must prepare for mandatory EUDAMED implementation from 28 May 2026.
What is European database on medical devices (EUDAMED)?
European database on medical devices (EUDAMED) is the European Commission’s centralized digital platform established under the EU Medical Device Regulation (MDR 2017/745). It is aimed to enhance transparency, traceability, and regulatory coordination across the European Union. It integrates six interconnected modules. Each module is designed to streamline regulatory processes, improve public access to device information, and strengthen post-market oversight. By centralizing data on medical devices, economic operators, clinical studies, and safety reports, EUDAMED supports harmonized market surveillance. Additionally, it fosters greater trust in the safety and performance of medical devices across the EU.
On 28May 2026, there will be mandatory EUDAMED implementation. EU medical device and IVD manufacturers must have a plan in place to comply with EUDAMED requirements and guidelines.
EUDAMED modules to comply with upon mandatory implementation
European database on medical devices is composed of six interlinked modules. Each module serves a distinct regulatory function to support EU MDR compliance. Together, they create a unified digital infrastructure for device regulatory oversight, transparency, and safety. EU medical device and IVD manufacturers will have to comply with four modules, namely Actor Registration (SRN), UDI and device registration, notified bodies and certificates, and market surveillance, from the date of mandatory EUDAMED implementation.
6 modules of EUDAMED
- Actor registration module: The actor registration module registers all economic operators, i.e., manufacturers, authorized representatives, importers, and clinical investigation sponsors. It assigns a Single Registration Number (SRN) to each actor, which is required for accessing other modules. This module establishes accountability and traceability of all parties involved in device lifecycle.
- UDI/device registration module: The UDI/device registration module captures Unique Device Identification (UDI) and device-specific data. Basic UDI-DI and UDI-DI entries, device risk class, intended purpose, and regulatory status are recorded. Thus, this module enables precise tracking of devices across the EU market and supports public transparency.
- Notified bodies and certificates module: This module records notified body details and conformity assessment certificates. CE certificates issued under MDR/IVD and scope of designation for each notified body are covered in this module. Hence, this module prevents duplication and fraud and allows competent authorities to monitor certification activities.
- Clinical investigations and performance studies module: This module focuses on applications, approvals, and results of clinical investigations (MDR) and performance studies (IVDR). It covers submission portal for sponsors as well as status tracking and result publication. It promotes harmonized evaluation and public access to clinical evidence.
- Vigilance and post-market surveillance module: This module focusses on centralizing reporting of serious incidents, Field Safety Corrective Actions (FSCA), and Periodic Safety Update Reports (PSURs). It covers incident trend analysis and coordination of corrective actions across member states. Thus, this module focusses on strengthening post-market safety and rapid response mechanisms.
- Market surveillance module: The market surveillance module enables competent authorities to share surveillance activities, findings, and enforcement actions. This module covers inspection reports and non-compliance alerts. This facilitates coordinated oversight and enforcement across the EU.
Key mandatory EUDAMED implementation deadlines
We have highlighted the major deadlines all medical device and IVD manufacturers in EU must keep in mind.
- 28 May 2026: Mandatory use of core EUDAMED modules
- 28 November 2026: Deadline to register legacy devices
- 28 May 2027: Completion of certificate uploads issued before 2026
Missing these deadlines may lead to regulatory findings or delay in market access.
What to expect upon mandatory EUDAMED implementation on 28 May 2026?
The EU medical device IVD market will see mandatory EUDAMED implementation on 28 May 2026. From 28 May 2026, EUDAMED stops being optional and becomes a legal obligation for all manufacturers under the EU MDR and IVDR. The European Commission confirmed that the following four modules are fully functional, triggering mandatory use.
Here is what becomes mandatory for manufacturers:
- Actor registration: All economic operators (manufacturers, authorized representatives, importers, distributors) must register in EUDAMED.
- UDI/Device registration: Each device must be registered with its Unique Device Identifier (UDI), thereby ensuring traceability across the EU market.
- Notified bodies and certificates: Certificates issued by Notified Bodies must be uploaded and maintained in EUDAMED.
- Market surveillance and vigilance coordination: Competent authorities and manufacturers must use EUDAMED for vigilance reporting and surveillance activities.
Key implications for manufacturers upon mandatory EUDAMED implementation:
- No more phased or voluntary use: Registration and data uploads are now compulsory and not optional.
- Transparency and public access: Certain data (e.g., device registration, certificates) will be publicly visible, thereby increasing scrutiny.
- Operational readiness: PRRCs must integrate EUDAMED into daily compliance workflows.
- Traceability and oversight: Stronger requirements for UDI management and vigilance reporting mean tighter control of device lifecycle data.
Therefore, from 28 May 2026, manufacturers must register themselves, their devices, and their certificates in EUDAMED. This marks the shift from a transitional, voluntary system to a mandatory, central EU compliance database.
How will manufacturers prepare for mandatory EUDAMED implementation? A step-by-step plan
We have prepared a step‑by‑step preparation plan for manufacturers to get ready for the mandatory EUDAMED implementation on 28 May 2026.
- Strategic alignment: Identify all devices, certificates, and economic operators that must be registered. Compare current data systems with EUDAMED requirements. Ensure your Person Responsible for Regulatory Compliance (PRRC) is responsible for EUDAMED compliance.
- Actor registration: Register your organization (manufacturer, AR, importer, distributor) in EUDAMED. Verify Single Registration Number (SRN) assignment for each actor. Align contracts with distributors/importers to ensure they also register.
- UDI and device data readiness: Ensure your UDI allocation and labeling are consistent with MDR/IVDR. Standardize device master data (names, risk class, intended use).If using machine‑to‑machine upload, validate your IT systems against EUDAMED’s specifications.
- Certificates and notified body coordination: Work with your Notified Body to ensure all valid certificates are uploaded. Establish a process for certificate lifecycle management (renewals, withdrawals, suspensions).Confirm visibility of certificates in the public EUDAMED interface.
- Vigilance and market surveillance: Train teams on incident reporting via EUDAMED. Update SOPs for vigilance reporting timelines and formats. Align with Competent Authorities on surveillance expectations.
- Go live with EUDAMED compliance on 28 May 2026: Ensure all actors, devices, and certificates are registered. Validate that vigilance reporting is functional. Conduct a mock audit to confirm readiness prior to the deadline.
- Post‑implementation monitoring: Monitor data accuracy and completeness. Track regulatory updates and guidance documents. Continuously train staff on EUDAMED updates and new modules (e.g., clinical investigations, performance studies).
Pharmadocx Consultants: Your trusted support for EU MDR and CE mark certificate
Mandatory EUDAMED implementation will kick in on 28 May 2026. Need help complying with the requirements? We have extensive expertise in EU MDR guidelines. Our team will provide all the help and support you need to comply with EUDAMED requirements. Additionally, you can email at [email protected] or call/Whatsapp on 9996859227 to avail our comprehensive CE mark certification service.
FAQs
Is EUDAMED mandatory from 28 May 2026?
Yes. From 28 May 2026 onwards, the core EUDAMED modules will become mandatory for EU medical device and IVD manufacturers.
Which EUDAMED modules will become mandatory in 2026?
Four EUDAMED modules will become mandatory:
Market Surveillance
Actor Registration (SRN)
UDI and Device Registration
Notified Bodies and Certificates
Do legacy devices need to be registered in EUDAMED?
Yes. Legacy devices already placed in the EU market prior to 28 May 2026 have to be registered in EUDAMED.
